Diabetes :: Rosiglitazone for type 2 diabetes – concern over side effects
New studies are needed to assess the trade-offs between potential benefits and potential harms when rosiglitazone is used by people with type 2 diabetes.
Type 2 diabetes
Diabetes :: Older Diabetes Drugs Have Similar or Superior Effects to Newer, Pricier Medications
A review of published literature about benefits and harms of oral drugs for type 2 diabetes mellitus found that older agents, such as second-generation sulfonylureas and metformin, have similar or superior effects on glycemic control, lipids and other intermediate endpoints compared to newer, more expensive drugs, such as thiazolidinediones, alpha-glucosidase inhibitors and meglitinides.
Juice :: Flavonoids in orange juice make it a healthy drink, despite the sugar
Orange juice, despite its high caloric load of sugars, appears to be a healthy food for diabetics due to its mother lode of flavonoids, a study by endocrinologists at the University at Buffalo has shown.
Diabetes :: Connecting diabetes and inflammation
It has long been known that type 1 diabetes is an autoimmune disease. The body attacks the islet cells in the pancreas that produce insulin.
Diabetes :: Most diabetes drugs provide similar glucose control
Most oral medications prescribed for type 2 diabetes are similarly effective for reducing blood glucose, but the drug metformin is less likely to cause weight gain and may be more likely than other treatments to decrease so-called bad cholesterol, according to a report funded by the Department of Health & Human Services’s (HHS) Agency for Healthcare Research and Quality (AHRQ).
Diabetes :: Older low-cost drugs are best buys for type 2 diabetes
Newer prescription drugs to treat type 2 diabetes ? including much-promoted Avandia and Actos ? are no more effective or safe than older drugs and cost significantly more, according to the latest report from Consumer Reports Best Buy Drugs, a public information project of Consumers U nion.
Metabolic Syndrome :: New definition helps identify children at risk of metabolic syndrome
The International Diabetes Federation (IDF) has launched a new definition to identify children and adolescents at increased risk of developing type 2 diabetes and cardiovascular disease in later life. The definition is published in The Lancet.
Diabetes :: Selenium supplements may increase the risk of type 2 diabetes
Selenium, an antioxidant included in multivitamin tablets thought to have a possible protective effect against the development of type 2 diabetes, may actually increase the risk of developing the disease, an analysis by researchers at the University at Buffalo has shown.
Diabetes :: Byetta for type 2 diabetes patients before insulin therapy
Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) welcomed the recent decision by the Scottish Medicines Consortium (SMC) on the use of BYETTA(R) (exenatide) in Scotland.
Obesity :: New blood test might offer early warning of deep belly fat
Measuring levels of a chemical found in blood offers the best indicator yet of the amount of fat surrounding abdominal organs, according to a new study of lean and obese individuals reported in the July issue of Cell Metabolism, a publication of Cell Press.